Teplizumab in Children with New Onset Type 1 Diabetes (T1D): Outcomes from the Phase 3 Study

Forgot your password?

Select specialty

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

February 13, 2024

Feat. V. Shah

Feat. A. Khattab

Ilene Fennoy

Practical Ways to Achieve Targets in Diabetes Care

University of Colorado Department of Medicine

Diana Isaacs

Feat. F. Pasquel

Keck School of Medicine of USC

Feat. M. Heyman

Practical Ways to Achieve Targets in Diabetes Care

Feat. J. Okemah

Keck School of Medicine of USC

R. Retnakaran

Michigan Medicine - Podiatry

G. Rothenberg

Robert Busch

Login

Login

Join VuMedi

Teplizumab in Children with New Onset Type 1 Diabetes (T1D): Outcomes from the Phase 3 Study

Unlock the Future of Type 2 Diabetes Care (featuring Dr. Viral Shah)

Managing CAH throughout Childhood and Adolescence

Related Videos

Obesity and Diabetes in Children

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Labs to Check on Semaglutide or Tirzepatide

Weightloss in Menopause

Tirzepatide Updates

Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Mind over diabetes: a psychologist’s take on the freedom of Omnipod®…

The Differences Between the Products of GLP1's and GLP/GIPs

Advancing Type 2 Diabetes Care with Omnipod® 5

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Optimizing Omnipod® 5 for Better Patient Outcomes (featuring Jennife…

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Mounjaro Update 2024

Can I Ever Be Cured? Strategies for Remission of Type 2 Diabetes

Wegovy 2024 Updates

Diabetic Peripheral Neuropathy: A Review of Clinical Practice Guidel…

Could It Be Cushing’s? Rethinking Diabetes Management with the CATAL…

Optimizing Omnipod 5 Therapy: Case Studies - TCOYD